# Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis

> **NCT01932151** · NA · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 18 (actual)

## Conditions studied

- Hepatorenal Syndrome

## Interventions

- **DRUG:** Terlipressin and albumin

## Key facts

- **NCT ID:** NCT01932151
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932151, "Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01932151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*